Bharat Biotech, Bilthoven Biologicals collaborate for oral polio vaccines production, supply, ET HealthWorld

[ad_1]

New Delhi : Bharat Biotech has collaborated with the Netherlands-based Bilthoven Biologicals B.V, a wholly-owned arm of Serum Institute of India, to strengthen production and supply security of oral polio vaccines.

An agreement has been signed between the two partners under which Bharat Biotech will procure drug substances for the production of oral polio vaccines (OPVs) to be supplied within India and globally, the company said in a statement.

Through this collaboration, Bharat Biotech and Bilthoven Biologicals (BBio) will jointly obtain regulatory approvals and licences required to commercially manufacture OPVs in India for global supplies from drug substances manufactured in the Netherlands at BBio.

Talking about the collaboration, Dr Krishna Ella, Executive Chairman of Bharat Biotech, said, “This collaboration between BBIL and BBio exemplifies cooperation between vaccine companies, ensuring a secure supply of oral polio vaccines and fortifies the nation’s mission to eradicate polio.”

Ella added that oral polio vaccines have been an integral part of India’s Universal Immunisation Programme (UIP) for several decades, with Bharat Biotech being one of the largest suppliers to immunisation programmes across the world.

Adar Poonawalla,CEO, Serum Institute of India said, “Our vision is to eradicate polio worldwide, taking a crucial step towards reducing the impact of this deadly disease on vulnerable populations.”

This collaboration will support the effort to create a polio-free world as the global polio eradication initiative approaches the critical phase, a statement said.

  • Published On Apr 2, 2024 at 01:37 PM IST

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

Download ETHealthworld App

  • Get Realtime updates
  • Save your favourite articles


Scan to download App


[ad_2]

Leave a Reply

Your email address will not be published. Required fields are marked *